These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 15673249)

  • 1. Design, synthesis, and binding affinities of pyrrolinone-based somatostatin mimetics.
    Smith AB; Charnley AK; Mesaros EF; Kikuchi O; Wang W; Benowitz A; Chu CL; Feng JJ; Chen KH; Lin A; Cheng FC; Taylor L; Hirschmann R
    Org Lett; 2005 Feb; 7(3):399-402. PubMed ID: 15673249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of receptor and receptor subtype affinities using diastereomeric and enantiomeric monosaccharide scaffolds as a means to structural and biological diversity. A new route to ether synthesis.
    Hirschmann R; Hynes J; Cichy-Knight MA; van Rijn RD; Sprengeler PA; Spoors PG; Shakespeare WC; Pietranico-Cole S; Barbosa J; Liu J; Yao W; Rohrer S; Smith AB
    J Med Chem; 1998 Apr; 41(9):1382-91. PubMed ID: 9554871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bioactive somatostatin analog without a type II' beta-turn: synthesis and conformational analysis in solution.
    Jiang S; Gazal S; Gelerman G; Ziv O; Karpov O; Litman P; Bracha M; Afargan M; Gilon C; Goodman M
    J Pept Sci; 2001 Oct; 7(10):521-8. PubMed ID: 11695647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pyrrolinone-based peptidomimetics. "Let the enzyme or receptor be the judge".
    Smith AB; Charnley AK; Hirschmann R
    Acc Chem Res; 2011 Mar; 44(3):180-93. PubMed ID: 21175156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catechol: A minimal scaffold for non-peptide peptidomimetics of the i + 1 and i + 2 positions of the beta-turn of somatostatin.
    Mowery BP; Prasad V; Kenesky CS; Angeles AR; Taylor LL; Feng JJ; Chen WL; Lin A; Cheng FC; Smith AB; Hirschmann R
    Org Lett; 2006 Sep; 8(20):4397-400. PubMed ID: 16986909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly potent 4-amino-indolo[2,3-c]azepin-3-one-containing somatostatin mimetics with a range of sst receptor selectivities.
    Feytens D; De Vlaeminck M; Cescato R; Tourwé D; Reubi JC
    J Med Chem; 2009 Jan; 52(1):95-104. PubMed ID: 19067538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Somatostatin receptor 1 selective analogues: 4. Three-dimensional consensus structure by NMR.
    Grace CR; Durrer L; Koerber SC; Erchegyi J; Reubi JC; Rivier JE; Riek R
    J Med Chem; 2005 Jan; 48(2):523-33. PubMed ID: 15658866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel somatostatin mimic with broad somatotropin release inhibitory factor receptor binding and superior therapeutic potential.
    Lewis I; Bauer W; Albert R; Chandramouli N; Pless J; Weckbecker G; Bruns C
    J Med Chem; 2003 Jun; 46(12):2334-44. PubMed ID: 12773038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and binding affinities of novel SRIF-mimicking beta-D-glucosides satisfying the requirement for a pi-cloud at C1.
    Angeles AR; Neagu I; Birzin ET; Thornton ER; Smith AB; Hirschmann R
    Org Lett; 2005 Mar; 7(6):1121-4. PubMed ID: 15760154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and binding properties of cyclohexapeptide somatostatin analogs containing naphthylalanine and arylalkyl peptoid residues.
    Tran TA; Mattern RH; Morgan BA; Taylor JE; Goodman M
    J Pept Sci; 1999 Mar; 5(3):113-30. PubMed ID: 10323556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular modeling suggests conformational scaffolds specifically targeting five subtypes of somatostatin receptors.
    Nikiforovich GV; Marshall GR; Achilefu S
    Chem Biol Drug Des; 2007 Mar; 69(3):163-9. PubMed ID: 17441902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel sst(4)-selective somatostatin (SRIF) agonists. 4. Three-dimensional consensus structure by NMR.
    Grace CR; Koerber SC; Erchegyi J; Reubi JC; Rivier J; Riek R
    J Med Chem; 2003 Dec; 46(26):5606-18. PubMed ID: 14667215
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational and topographical considerations in the design of biologically active peptides.
    Hruby VJ
    Biopolymers; 1993 Jul; 33(7):1073-82. PubMed ID: 8102072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of somatostatin mimetics based on 1-deoxynojirimycin.
    Chagnault V; Lalot J; Murphy PV
    ChemMedChem; 2008 Jul; 3(7):1071-6. PubMed ID: 18418832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parallel synthesis and biological evaluation of different sizes of bicyclo[2,3]-Leu-enkephalin analogues.
    Gu X; Ying J; Min B; Cain JP; Davis P; Willey P; Navratilova E; Yamamura HI; Porreca F; Hruby VJ
    Biopolymers; 2005; 80(2-3):151-63. PubMed ID: 15660379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological activities of potent and selective somatostatin analogues incorporating novel peptoid residues.
    Tran TA; Mattern RH; Afargan M; Amitay O; Ziv O; Morgan BA; Taylor JE; Hoyer D; Goodman M
    J Med Chem; 1998 Jul; 41(15):2679-85. PubMed ID: 9667958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biologic activity of conformationally constrained analogs of L-363,301.
    Moore SB; Grant M; Rew Y; Bosa E; Fabbri M; Kumar U; Goodman M
    J Pept Res; 2005 Dec; 66(6):404-22. PubMed ID: 16316457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel pyrazolopiperazinone- and pyrrolopiperazinone-based MCH-R1 antagonists.
    Meyers KM; Méndez-Andino J; Colson AO; Hu XE; Wos JA; Mitchell MC; Hodge K; Howard J; Paris JL; Dowty ME; Obringer CM; Reizes O
    Bioorg Med Chem Lett; 2007 Feb; 17(3):657-61. PubMed ID: 17174091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A light-activated beta-turn scaffold within a somatostatin analog: NMR structure and biological activity.
    Ulysse LG; Chmielewski J
    Chem Biol Drug Des; 2006 Feb; 67(2):127-36. PubMed ID: 16492160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of somatostatin mimetics based on the 1-deoxymannojirimycin scaffold.
    Gouin SG; Murphy PV
    J Org Chem; 2005 Oct; 70(21):8527-32. PubMed ID: 16209603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.